A paradigm shift in diabetic wound care: Multifunctional silk fibroin-glycidyl methacrylate hydrogels delivering stem cell and immune cell secretome.
Silli EK., Wang K., Xiao Z., Liu T., Zhang L., Zhu J.
Prospective Study on Diabetic Foot, Chronic Wound, Immune Modulation, published in Int J Biol Macromol (2026) — summary generated from the PubMed abstract.
Early human evidence such as case series or small samples is exploring possible benefits.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Prospective Study
- Journal
- Int J Biol Macromol (2026)
- Country
- Netherlands
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 41554360
- DOI
- 10.1016/j.ijbiomac.2026.150363
Abstract (original English)
Chronic wounds in diabetic patients remain a significant clinical challenge due to neuropathy, vascular dysfunction, and persistent inflammation. In this study, we engineered a multifunctional wound dressing by incorporating conditioned media (CM) including secretome derived from three cell sources, natural killer (NK) cells, adipose-derived mesenchymal stem cells (ADMSCs), and umbilical cord mesenchymal stem cells (UCMSCs) into a silk fibroin-glycidyl methacrylate (SF-GMA) hydrogel scaffold. The formed SF-GMA hydrogel exhibited a porous, hydrated architecture with an optimal curing time of 15 s, a compressive modulus of 101 ± 2 KPa and favorable biocompatibility. Cytokine profiling revealed that all CM types were rich in pro-regenerative factors. In vitro assays showed that CM promoted endothelial tube formation and enhanced fibroblast and keratinocyte migration under hyperglycemic conditions. In a streptozotocin-induced diabetic mouse model, CM-loaded SF-GMA hydrogels significantly accelerated wound closure (90 ± 8.21%) compared to controls (30 ± 5.20%) by day 14. Histological analysis revealed improved re-epithelialization, granulation tissue formation, and collagen deposition, while immunofluorescence indicated enhanced neovascularization and reduced inflammation. Notably, ADMSC-CM most strongly promoted angiogenesis, whereas NK-CM enhanced epithelial migration. Overall, CM
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
Evidence level
Early human evidence such as case series or small samples is exploring possible benefits.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level AMeta-analysisPubMed
Efficacy of Stem Cell-Derived Exosomes in Promoting Diabetic Foot Ulcer Healing: A Meta-Analysis of Preclinical Animal Studies.
Meta-analysis on Diabetic Foot, Chronic Wound, published in J Diabetes Res (2026) — summary generated from the PubMed abstract.
- 2026
J Diabetes Res - Level AMeta-analysisEurope PMC
Bone marrow-derived mesenchymal stem cells combined with intramuscular injection promote the healing of diabetic foot ulcers: a systematic review and meta-analysis
Meta-analysis with a reported sample of 2059 on Diabetic Foot, Chronic Wound, published in Front Endocrinol (Lausanne) (2026) — summary generated from the PubMed abstract.
- 2026
- n = 2059
Front Endocrinol (Lausanne) - Level AMeta-analysisEurope PMC
Comparative efficacy of advanced therapeutic modalities for diabetic foot ulcers: a systematic review and meta-analysis including NPWT, stem cells, ESWT, and bioengineered treatments
Meta-analysis on Diabetic Foot, published in Front Bioeng Biotechnol (2026) — summary generated from the PubMed abstract.
- 2026
Front Bioeng Biotechnol - Level AMeta-analysisPubMed
Therapeutic potential of adipose-derived stem cells for diabetic foot ulcers: a systematic review and meta-analysis.
Meta-analysis on Diabetic Foot, Chronic Wound, published in Diabetol Metab Syndr (2025) — summary generated from the PubMed abstract.
- 2025
Diabetol Metab Syndr6 citations - Level AMeta-analysisPubMed
A meta-analysis on application and prospect of cell therapy in the treatment of diabetes mellitus.
Meta-analysis on Diabetic Foot, Autoimmune Research, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther - Level AMeta-analysisEurope PMC
Comparison of the efficacy of 12 interventions in the treatment of diabetic foot ulcers: a network meta-analysis
Meta-analysis with a reported sample of 356 on Diabetic Foot, Chronic Wound, published in PeerJ (2025) — summary generated from the PubMed abstract.
- 2025
- n = 356
PeerJ1 citations